# The Study of MicroRNA Genomics of Blood Stasis Syndrome and of Coronary Heart Disease

> **NCT01615003** · PHASE2 · UNKNOWN · sponsor: **Guang'anmen Hospital of China Academy of Chinese Medical Sciences** · enrollment: 70 (estimated)

## Conditions studied

- Coronary Heart Disease
- Unstable Angina
- Blood Stasis Syndrome

## Interventions

- **DRUG:** Xuesaitong soft capsule
- **DRUG:** Xuesaitong soft capsule Placebo

## Key facts

- **NCT ID:** NCT01615003
- **Lead sponsor:** Guang'anmen Hospital of China Academy of Chinese Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-05
- **Primary completion:** 2014-07
- **Final completion:** 2014-12
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2014-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01615003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01615003, "The Study of MicroRNA Genomics of Blood Stasis Syndrome and of Coronary Heart Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01615003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*